RxPost
Setting the Scene
Every year, independent pharmacies, making up 36% of all U.S. locations, lose hundreds of thousands of dollars to expired inventory.
To stay competitive with national chains, they must stock a broad range of medications, even those that rarely get filled.
However, that breadth comes at a cost: drugs sit on shelves longer, cash gets tied up, and margins shrink, especially for smaller operators.
This week’s company helps pharmacies offer more without wasting more, by cutting the surplus costs that strain their margins.
In a Sentence
RxPost is an inventory platform and marketplace helping pharmacies manage, resell, and optimize surplus inventory.
Platform: Pharmacies use RxPost to track inventory, manage purchases, and flag surplus medications before they become costly waste, streamlining operations and improving purchasing decisions.
Marketplace: A secure, compliant marketplace where pharmacies list surplus medications and sell directly to vetted buyers such as pharmacies, wholesalers, and other licensed healthcare entities.
Bulleted Version:
- Just like Amazon powers third-party sellers with both logistics tools and a massive marketplace, RxPost equips independent pharmacies with inventory software and a resale platform to recover value from surplus meds.
The Basics
- Headquarters: Los Angeles, CA
- Employee Count: 10
- Funding amount: $2M
- Business model: SaaS subscription, B2B marketplace with a 10% take rate
- Early traction: $2.7M ARR, 33% MoM growth, profitable operations
Due Diligence
WHAT WE LIKE
Market Opportunity: Independent pharmacies spend $4.4M a year on medications, and with 3.5% expiring, about $150,000 per pharmacy, waste adds up quickly across more than 19,000 locations nationwide.
Strategic Expansion Path: By starting with surplus management and expanding into clinical tools such as billing, accreditation, and training, RxPost is building an all-in-one system that helps independent pharmacies compete with national chains.
Network Effects: Every new pharmacy strengthens the network by both saving money and adding inventory others can buy, fueling a virtuous cycle of cost savings, transparency, and liquidity.
POTENTIAL RISKS
Workflow Integration: Pharmacies rely on varied and sometimes outdated systems, which could make seamless integration challenging in the early stages.
Inventory Quality Assurance: Ensuring surplus medications are stored, handled, and verified correctly across sellers may introduce operational or legal challenges at scale.
Scaling Sales: With thousands of independent pharmacies, customer acquisition may require highly localized, resource-intensive efforts to grow efficiently.
Founder Profile
Amantha Bagdon, CEO: 20 years of pharmacy tech experience.
Comps
InStockRx: A pharmacy-to-pharmacy marketplace enabling surplus stock listing and acquisition; less SaaS and inventory management capabilities.
MatchRX: Marketplace designed for independent pharmacies to buy/sell overstock non-controlled prescription drugs and access wholesale pricing, no SaaS or inventory management that RxPost provides.
EzriRx: A pharmaceutical purchasing platform where pharmacies of any size can access tens of thousands of SKUs from a broad wholesaler network, limited marketplace focus for pharmacies needing rapid and one-off medications.
Why RxPost
By transforming surplus inventory into recovered value and equipping independent Pharmacies with chain-level operational tools, RxPost might be the cure for helping independent pharmacies compete with the chains.
